XIX International AIDS Conference

Abstract

Close
Sign In
Back

WEPE622 - Poster Exhibition


Impacting PCP prophylaxis prescribing through a collaborative approach

R. Smith1, L. Lago2, J. Britanik1, T. Austin3, L. Buckner4, M. Cameron3, A. Clements5, S. Diawara6, A. Farquaharson7, J. Gathua5, A. Khalil8, T. Moore9, A. Rhodes6, A. Wood10, DC Cross-Part (HIV) Collaborative Response Team

1Greater Baden Medical Services, Inc, Development, Brandywine, United States, 2DC Department of Health, Washington, United States, 3DC Cross Part HIV Collaborative, Washington, United States, 4Carl Vogel Center, Washington, United States, 5Inova Health Care Services, Springfield, United States, 6Virginia Department of Health, Richmond, United States, 7Howard University Hospital Comprehensive Clinic, Washington, United States, 8Northern Virginia Regional Commission, Fairfax, United States, 9Children's National Medical Center, Washington, United States, 10Family and Medical Counseling, Washington, United States

Background: In January 2011, the DC Cross-Part HIV Collaborative was formed to improve the overall care of HIV patients in the region. The collaborative consists of over 35 Ryan White funded agencies in the District of Columbia, Maryland, Virginia and West Virginia. The Collaborative reported on 15 Clinical performance measures for participating providers.
Methods: For PCP prophylaxis, the measure was defined as explained in Table A. Beginning in March 2011, 37% of agencies (13) reported client level data bi-monthly representing a patient load of 1,028 per/year.
Results: The 1st round of baseline data collection resulted in an EMA mean performance of (58%). Round 4 data showed a variance of (33%). The final mean score of (91%) showed significant improvement and exceeded the intended goal of 90% (See Graph 1).

Graph 1
[Graph 1]

Data was aggregated to obtain EMA (Eligible Metropolitan Area)-wide results. Please see Table A for details.

Table A
[Table A]

Table B shows reporting in Sept 2011 from 49% of agencies (17) with over 1,303 patients.

Table B
[Table B]

Success factors include agency clean-up of data, process improvements, more consistent reporting, and a better understanding of the importance of PCP prophylaxis prescribing. While the sample population was predominantly Black/African-American; all racial/ethnic groups showed substantial improvement from baseline.
Conclusions: By using a regional approach agencies achieved a significant improvement in performance on PCP prophylaxis prescribing which will decrease opportunistic infection, improve the health of those with HIV and strengthen the region's clinical management of those with HIV/AIDS.

Download the e-Poster


Back to the Programme-at-a-Glance


Contact Us | Site map © 2012 International AIDS Society